Torrey Pines Investment is the famous VC, which was founded in 2002. The leading representative office of defined VC is situated in the San Diego. The company was established in North America in United States.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Health Diagnostics, Genetics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Chromis Therapeutics, Viriom, Avelas Biosciences. The fund has specific favorite in a number of founders of portfolio startups.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Torrey Pines Investment, startups are often financed by MIT RF, ChemRar Ventures, Avalon Ventures. The meaningful sponsors for the fund in investment in the same round are Avalon Ventures, WuXi Healthcare Ventures, WuXi AppTec. In the next rounds fund is usually obtained by WuXi Healthcare Ventures, Pharmstandard, MIT RF.
The fund was created by Nikolay Savchuk. We also calculated 3 valuable employees in our database.
The important activity for fund was in 2012. This Torrey Pines Investment works on 24 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2016.
Related Funds
Funds with similar focus
Fund Name | Location |
DD3 Capital Partners | Ciudad De León, Guanajuato, Mexico |
Eastern Link Capital | Boston, Massachusetts, United States |
Fearnley Securities | Norway, Oslo |
IMAF-RTP | Cary, North Carolina, United States |
Kamakura Shinsho | Chiyoda, Japan |
Salex Capital | - |
Star Energy | Iowa, Manson, United States |
Techpro Ventures | India, Maharashtra, Mumbai |
Tianfutai Shanghai Xincailiao Keji | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Polku Therapeutics | $2M | 17 Sep 2024 | Helsinki, Southern Finland, Finland | ||
Brenig Therapeutics | $65M | 24 Jul 2024 | Dover, Delaware, United States | ||
Chromis Therapeutics | 06 Jun 2016 | San Diego, California, United States | |||
Chromis Therapeutics | $3M | 26 Feb 2016 | San Diego, California, United States | ||
28 Feb 2015 | Cambridge, Massachusetts, United States | ||||
Avelas Biosciences | $7M | 10 Sep 2014 | San Diego, California, United States | ||
Avelas Biosciences | $6M | 09 Jan 2014 | San Diego, California, United States | ||
TeaRx | 02 Aug 2012 | Moscow, Moscow, Russia | |||
SatRx | 14 Jul 2012 | Khimki, Moscow Oblast, Russia |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Polku Therapeutics | $2M | 17 Sep 2024 | Helsinki, Southern Finland, Finland | ||
Brenig Therapeutics | $65M | 24 Jul 2024 | Dover, Delaware, United States | ||
Chromis Therapeutics | 06 Jun 2016 | San Diego, California, United States | |||
Chromis Therapeutics | $3M | 26 Feb 2016 | San Diego, California, United States | ||
28 Feb 2015 | Cambridge, Massachusetts, United States | ||||
Avelas Biosciences | $7M | 10 Sep 2014 | San Diego, California, United States | ||
Avelas Biosciences | $6M | 09 Jan 2014 | San Diego, California, United States | ||
TeaRx | 02 Aug 2012 | Moscow, Moscow, Russia | |||
SatRx | 14 Jul 2012 | Khimki, Moscow Oblast, Russia |